top of page
Home
All News
Members
More
Use tab to navigate through the menu items.
Search
Rx News
News
Trials
Cases
Log In
All Posts
Guidelines
Clinical Trials
Patient Stories & PEL
Case Reports
New Approvals
Spotlight
Role of CARVYKTI® in the treatment of Multiple Myeloma
Multiple myeloma (MM) is one of the most common haematological cancers, with an incidence rate of 10%. As per the GLOBOCON 2022 update,...
Ms. Tanvi Goel
Sep 10, 2025
5 min read
Back to Top
bottom of page
